Strong Market Presence BioSerenity collaborates with over 200 hospitals across Europe, showcasing its established footprint in the healthcare sector and potential for expanding partnerships with medical institutions seeking advanced digital diagnostic solutions.
Recent Investment Growth With a recent €24 million investment from JOLT Capital and notable funding rounds reaching €65 million, BioSerenity demonstrates robust financial backing, indicating readiness for scaling its connected medical device offerings.
Technology Leadership The company’s focus on integrating sensors, IoT platforms, AI, and textile innovations highlights its position at the technological forefront, providing opportunities to introduce complementary services or hardware solutions in neurodiagnostics and chronic disease monitoring.
Partnership Opportunities Strategic collaborations with industry leaders like Stratus Neuro and APRIL International suggest a readiness for expanding its network through joint ventures or OEM relationships to reach broader markets and enhance product adoption.
High Growth Potential With a revenue estimate of up to $25 million and rapid funding inflows, BioSerenity presents a promising target for sales initiatives aimed at expanding its digital health ecosystem, including software, data analytics, and device complement offerings.
BioSerenity uses 8 technology products and services including Ansible, Open Graph, Snowflake, and more. Explore BioSerenity's tech stack below.
| BioSerenity Email Formats | Percentage |
| First.Last@bioserenity.com | 96% |
| Last@bioserenity.com | 2% |
| FirstLast@bioserenity.com | 1% |
| Last.First@bioserenity.com | 1% |
Medical Equipment ManufacturingFrance201-500 Employees
BioSerenity develops connected medical solutions to help diagnose and monitor patients with chronic diseases in neurology, sleep disorders and cardiology. We use physiological sensors, an IoT platform, apps and A.I. to detect digital biomarkers. We work with more than 200 hospitals in Europe and help diagnose over a hundred thousand patients per year. Our headquarter is in Paris, France.
Company Overview
Media & News
Funding & FinancialsBioSerenity has raised a total of $26M of funding over 7 rounds. Their latest funding round was raised on Nov 13, 2023 in the amount of $26M.
BioSerenity's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsBioSerenity has raised a total of $26M of funding over 7 rounds. Their latest funding round was raised on Nov 13, 2023 in the amount of $26M.
BioSerenity's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com